Medtronic (NYSE:MDT) and nonprofit org Tidepool announced last week that the groups will work together to develop an interoperable, automated insulin delivery system. The medtech giant reported that it plans to build a Bluetooth-enabled MiniMed pump that is compatible with Tidepool’s Loop app, an open-source app for automated insulin delivery. Both companies plan to work […]
EuroPCR 2019: Paclitaxel meta-analysis a ‘typhoon in a teapot’
The meta-analysis that suggested there was a link between paclitaxel-coated devices and heightened mortality compared to bare devices was described as a “typhoon in a teapot” at this year’s EuroPCR meeting, according to a report from MedScape. Dr. Alexandra Lansky of Yale University School of Medicine, who authored the organization’s formal statement on the matter, reportedly […]
DeviceTalks partners with New England Healthcare Executive Network to host mergers & acquisition panel at DeviceTalks Boston
The New England Healthcare Executive Network will host a panel of leaders to discuss the topic of mergers and acquisitions in the medical device industry. For the third consecutive year, DeviceTalks has partnered with the New England Healthcare Executive Network at DeviceTalks Boston. At DeviceTalks Boston 2019, NE Healthcare Executive Network’s member meeting will offer […]
DeviceTalks Boston partners with not-for-profit veteran organization MVPvets
(Press Release) – DeviceTalks is proud to announce today a partnership with MVPvets, a not-for-profit group that assists and prepares transitioning military veterans for meaningful employment in life science companies. Piloted in 2012 as a collaborative venture with multiple medical device firms such as Abiomed, Johnson & Johnson and AdvaMed, a trade association for the […]
DeviceTalks Boston: Here’s why you should get excited
There’s a lot to look forward to at DeviceTalks Boston, June 5–6 at the Seaport World Trade Center. Sarah Faulkner, Program Manager – DeviceTalks Eight years ago, DeviceTalks kicked off its inaugural event in Boston with a keynote interview featuring Abiomed’s chief executive, Michael Minogue. The evening program, which consisted of a keynote, cocktails and dinner, […]
Breath Therapeutics launches Ph3 trial for inhaled liposomal cyclosporine A therapy
Privately-held Breath Therapeutics said today that it kicked off a Phase III clinical program for its liposomal formulation of cyclosporine A for the treatment of bronchiolitis obliterans syndrome. The company’s primary drug candidate, L-CsA-i, is an inhaled therapy delivered via Pari Pharma‘s investigational eFlow nebulizer. The Boston-1 trial is slated to enroll people with BOS […]
Medtronic responds to usability concerns for its MiniMed 670G insulin pump
Medtronic (NYSE:MDT) responded to a study presented this week which highlighted usability concerns with its MiniMed 670G automated insulin pump, writing that the company had “made many enhancements to the system since the study was done which would likely mitigate many of the issues experienced.” Earlier this week, physicians from Boston Children’s Hospital reported that nearly […]
Study examines usability of hybrid closed-loop insulin pump
Data from an 83-person study of Medtronic‘s (NYSE:MDT) MiniMed 670G hybrid closed-loop insulin pump showed that nearly one-fifth of participants stopped using the device after struggling with the technical demands of the system, researchers reported. Medtronic’s MiniMed 670G device is designed to automatically track and adjust a patient’s blood sugar levels by measuring blood glucose […]
DeviceTalks partners with MassMEDIC to highlight the Massachusetts medical device ecosystem at DeviceTalks Boston
For the second year, DeviceTalks and MassMEDIC have partnered to bring the MassMEDIC MedTech Showcase to DeviceTalks Boston on June 5-6. Boston, MA and Cleveland, OH – DeviceTalks is proud to announce that it has partnered with MassMEDIC for the second year to bring the MassMEDIC MedTech Showcase to DeviceTalks Boston on June 5-6 at […]
Senseonics touts patient access program for Eversense CGM
Senseonics (NYSE:SENS) said today that it launched the Eversense Bridge Program, which is designed to improve patient access to Senseonics’ Eversense continuous glucose monitoring system. The company said that the program can help users confirm their insurance benefits and obtain pre-authorization before sensor placement. The Eversense Bridge Program is also meant to help healthcare providers and patients […]
